April 13, 2022 article Open access Impact of Manufacturing Procedures on CAR T Cell Functionality Frontiers in Immunology DOI: 10.3389/fimmu.2022.876339 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 197 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study 2026 The Lancet Haematology article Medicine CAR-T cell therapy research 0 citations Automating chimeric antigen receptor T-cell manufacturing across distinct platforms delivers similar cell quality, phenotype and function 2026 Cytotherapy article Medicine CAR-T cell therapy research Open access 0 citations Optimizing CAR-T treatment: A T2EVOLVE guide to raw and starting material selection 2024 Molecular Therapy article Medicine CAR-T cell therapy research Open access 9 citations 3 results References 0